Effient FDA Approval History
FDA Approved: Yes (First approved July 10, 2009)
Brand name: Effient
Generic name: prasugrel
Dosage form: Tablets
Company: Daiichi Sankyo Company, Limited and Eli Lilly and Company
Treatment for: Acute Coronary Syndrome
Effient (prasugrel) is an oral antiplatelet agent for the treatment of patients with acute coronary syndrome (ACS) who are managed with percutaneous coronary intervention including coronary stenting.
Development timeline for Effient
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.